Copy For Citation
KISKAÇ M., ZORLU M., ÇAKIRCA M., KARATOPRAK C., Peru C., Erkoc R., ...More
INDIAN JOURNAL OF PHARMACOLOGY, vol.45, no.3, pp.305-306, 2013 (SCI-Expanded)
Article / Article
INDIAN JOURNAL OF PHARMACOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Recep Tayyip Erdoğan University Affiliated:
Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure.